Public Company News

Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026

Haier Biomedical Accelerates Its Transformation into an Intelligent Biopharmaceutical Infrastructure Platform at ISPE Singapore 2026 SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Haier Biomedical  (SHA: 688139) showcased a portfolio of automated and digital solutions sp...

2026-09-01 22:50 1

Intercontinental Exchange Adds to Weather Tracking Features: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 1, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-09-01 20:56 812

Global-Leading Robobrain Firm Mech-Mind Robotics Lists on Hong Kong Stock Exchange

SHANGHAI, Sept. 1, 2026 /PRNewswire/ -- Mech-Mind Robotics, a portfolio company of Qiming Venture Partners and a global-leading robobrain company, successfully listed on the Hong Kong Stock Exchange on September 1, 2026 Beijing time and became the first listed embodied intelligence "Eye-Brain-Han...

2026-09-01 20:16 992

QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery

Joint test on IonQ Forte hardware lands within 4% of benchmark, clearing the chemical-accuracy bar for enzyme active-site modeling via Amazon Braket PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ -- QC Ware today announced a technology demonstration of a hybrid quantum-classical chemistry workflow...

2026-09-01 20:00 1280

Ribbon Bolsters Its Market-Leading Critical Infrastructure Portfolio

New generation of routers delivers expanded routing, automation, security and synchronization capabilities PLANO, Texas, Sept. 1, 2026 /PRNewswire/ -- Ribbon Communications Inc.

2026-09-01 20:00 1146

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy

Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was Well Tolerated as Monotherapy and in Combination with Checkpoint Inhibition Kazia is Preparing to Advance Pa...

2026-09-01 19:30 789

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer

Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and Produces Statistically Significant Antitumor Activity Three-Arm Expansion of the Ongoing TNBC Trial Will Evaluate Paxalisib Plus Fulvestrant, With Palbociclib, Versus Standard-of-Care First Patient Expec...

2026-09-01 19:15 1216

Xiami Music & Arts Festival Returns for 5th Edition with The Cardigans Leading a Global Lineup

* The festival has presented 33 international acts over the past five years. * It has expanded beyond music to encompass theater, exhibitions, film, designer toys and other forms of entertainment. * This year's festival secured partnerships with 30 brands, continuing the growth of its commer...

2026-09-01 17:36 1573

Xcite Uranium Commences Drilling at the Past-Producing Lorado Uranium Project, Saskatchewan

VANCOUVER, BC, Sept. 1, 2026 /PRNewswire/ -- Xcite Uranium Inc. (CSE: XRI) (" Xcite" or the "Company") is pleased to announce the commencement of the diamond drilling program at theLorado Uranium Project located near Uranium City, Saskatchewan.  The 1200m, 3-hole program will test for uranium min...

2026-09-01 16:00 589

Zoomlion Strengthens European Localization through Expanded Service, Manufacturing, and Technology Collaboration

CHANGSHA, China, Sept. 1, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion" or "the Company") is strengthening its localized operations in Europe following a partner meeting held on August 19 at Zoomlion's factory in Germany and a visit to its German subsidia...

2026-09-01 15:26 1277

JIANGXI BIO Announced 2026 Interim Results

Overseas Contract Orders Reach Nearly RMB27.4 mn and R&D Translation Gains Momentum, with the AEPC Platform Reshaping the R&D Paradigm for Equine Polyclonal Antibody Interim Results Highlights   Key Financial Indicators * Revenue amounted to RMB83.3 mn; gross profit amounted to RMB60.3 mn, ...

2026-09-01 14:44 1399

Furuno Unveils New SOLION-100 Terminal for Iridium GMDSS

The SOLION-100 combines GMDSS, Ship Security Alert System and Long-Range Identification and Tracking capabilities in a single Iridium Certus 100 terminal for newbuild and retrofit vessels. HAMBURG, Germany, Sept. 1, 2026 /PRNewswire/ -- Iridium Communications Inc.

2026-09-01 13:01 1249

Otis Appoints Sridhar Rajagopal to Lead Southeast Asia Business

* Leading growth and strengthening customer engagement SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- Otis  (NYSE: OTIS), the world's leading elevator and escalator manufacturing, installation, service and modernization company,today announced the appointment of Sridhar Rajagopa...

2026-09-01 12:00 1380

UJU HOLDING 2026 Interim Results: Synergistic Development Across the Diversified Business Matrix, the "Reengineering UJU Overseas" Strategy Sets Sail, and AI Drives Comprehensive Business Upgrades

BEIJING and HONG KONG, Sept. 1, 2026 /PRNewswire/ -- UJU HOLDING (hereinafter referred to as the "Company" or the "Group") announced its 2026 interim results. In the first half of 2026, against the backdrop of the digital marketing industry accelerating its shift from traffic expansion to techno...

2026-09-01 10:30 1872

Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering

Company to host a corporate update call Tuesday, September 1st at 8:00am ET SYDNEY, Sept. 1, 2026 /PRNewswire/ -- Kazia Therapeutics Limited  (NASDAQ: KZIA) ("Kaz...

2026-09-01 07:23 1983

Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia

The next generation in skin resurfacing technology is available to Australian health care practitioners beginning 1 September 2026 LAVAL, QC, Sept. 1, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), a global, diversified pharmaceutical company, and its aesthetics busines...

2026-09-01 06:00 1359

YY Group Enters New Era as YYForce, Expanding AI, Automation and Human-Robot Workforce Strategy; Nasdaq Ticker Changes to "YFOR"

New name reflects evolution into automation and AI-enabled workforce management and integrated facility management (IFM) infrastructure platform Trading under new ticker symbol YFOR expected to commence September 2, 2026 SINGAPORE, Sept. 1, 2026 /PRNewswire/ -- YY Group Holding Limited (NASDAQ: ...

2026-09-01 04:10 2930

Vanguard 500 Index Fund Turns 50: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 31, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-08-31 22:40 1855

CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

CS2009 Achieved Key Clinical Validations for Efficacy and Safety As of August 2026, updated data further confirmed the favorable safety profile of CS2009 and demonstrated strengthened efficacy across multiple key cohorts compared with the data presented at ASCO in May 2026. With expanded patient...

2026-08-31 20:38 1564

Rockwell Automation Integrates Plex QMS with FactoryTalk Analytics VisionAI to Advance AI-Driven Quality, Continues AI Expansion

Integration brings AI-powered visual inspection into QMS workflows to help  improve quality, traceability and defect detection MILWAUKEE, Aug. 31, 2026 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE:ROK), the world's largest company dedicated to industrial automation and digital transformation,...

2026-08-31 19:24 439
12345 ... 903